Alamar Biosciences, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +3.5% | +27.0% | -2.8% | |
| – | +9.9% | +115.7% | +223.6% | |
| – | – | – | – | |
| – | +13.5% | -46.2% | +507.0% | |
| – | – | – | +15,426.5% | |
| – | – | – | -100.0% | |
| – | -32.5% | +33,900.6% | +262.0% | |
| – | +51.7% | +884.1% | +5.9% | |
| – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.